Next Quarterly Earnings
Thursday, October 22, 2026
CW 43
Pre-Market
In 55 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
arGEN-X
arGEN-X is a leading biotechnology company headquartered in the Netherlands, dedicated to developing innovative antibody therapies. The company researches and develops novel medicines to treat severe autoimmune diseases and various types of cancer, aiming to improve patient lives globally.
Frequently asked questions
When will arGEN-X report its next quarterly earnings?
arGEN-X is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did arGEN-X last report quarterly earnings?
arGEN-X last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 6.44 EUR.
How does arGEN-X stock react to earnings?
Across its last 4 earnings reports, arGEN-X stock moved by ±4.2% on average the following day. The largest reaction was +8.6% on 07/23/2026; 1 of 4 reactions were positive.
How often has arGEN-X beaten expectations?
arGEN-X has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the arGEN-X earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±4.2%
Avg. next-day move
+8.6%
Largest move (07/23/2026)
25%
Share of positive reactions
±4.7%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+10.9%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
arGEN-X
Country
🇳🇱
Index membership
More Financial Information